Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Hummel

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Transplantation|December 6, 2003
The heart-allocation simulation model: a tool for comparison of transplantation allocation policiesWilbert B van den Hout, Jacqueline M A Smits, Mario C Deng, et al.
Transplantation|December 20, 2007
A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimusJames A Hill, Manfred Hummel, Randall C Starling, et al.
Transplantation|April 27, 2007
Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximabRalf Trappe, Hanno Riess, Nina Babel, et al.
Transplantation|October 28, 2003
A prognostic model for predicting waiting-list mortality for a total national cohort of adult heart-transplant candidatesJacqueline M A Smits, Mario C Deng, Manfred Hummel, et al.
Annals of Hematology|April 6, 2006
Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical courseStephan Oertel, Ralf Ulrich Trappe, Kristin Zeidler, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 7, 2007
Observational study with everolimus (Certican) in combination with low-dose cyclosporine in de novo heart transplant recipientsHans B Lehmkuhl, Daniel Mai, Michael Dandel, et al.
ESC Heart Failure|January 7, 2022
Comparison of feasibility and results of frailty assessment methods prior to left ventricular assist device implantationLuise Roehrich, Simon H Sündermann, Isabell Anna Just, et al.
Pacing and Clinical Electrophysiology : PACE|July 23, 2020
Safety of bioelectrical impedance analysis in advanced heart failure patientsLuise Roehrich, Simon Suendermann, Isabell Anna Just, et al.
Frontiers in Cardiovascular Medicine|November 4, 2021
Impact of Muscle Mass as a Prognostic Factor for Failed Waiting Time Prior to Heart TransplantationLuise Roehrich, Simon H Suendermann, Isabell Anna Just, et al.
The New England Journal of Medicine|August 29, 2003
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipientsHoward J Eisen, E Murat Tuzcu, Richard Dorent, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Transplantation|December 6, 2003
The heart-allocation simulation model: a tool for comparison of transplantation allocation policiesWilbert B van den Hout, Jacqueline M A Smits, Mario C Deng, et al.
Transplantation|December 20, 2007
A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimusJames A Hill, Manfred Hummel, Randall C Starling, et al.
Transplantation|April 27, 2007
Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximabRalf Trappe, Hanno Riess, Nina Babel, et al.
Transplantation|October 28, 2003
A prognostic model for predicting waiting-list mortality for a total national cohort of adult heart-transplant candidatesJacqueline M A Smits, Mario C Deng, Manfred Hummel, et al.
Annals of Hematology|April 6, 2006
Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical courseStephan Oertel, Ralf Ulrich Trappe, Kristin Zeidler, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 7, 2007
Observational study with everolimus (Certican) in combination with low-dose cyclosporine in de novo heart transplant recipientsHans B Lehmkuhl, Daniel Mai, Michael Dandel, et al.
ESC Heart Failure|January 7, 2022
Comparison of feasibility and results of frailty assessment methods prior to left ventricular assist device implantationLuise Roehrich, Simon H Sündermann, Isabell Anna Just, et al.
Pacing and Clinical Electrophysiology : PACE|July 23, 2020
Safety of bioelectrical impedance analysis in advanced heart failure patientsLuise Roehrich, Simon Suendermann, Isabell Anna Just, et al.
Frontiers in Cardiovascular Medicine|November 4, 2021
Impact of Muscle Mass as a Prognostic Factor for Failed Waiting Time Prior to Heart TransplantationLuise Roehrich, Simon H Suendermann, Isabell Anna Just, et al.
The New England Journal of Medicine|August 29, 2003
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipientsHoward J Eisen, E Murat Tuzcu, Richard Dorent, et al.
Pageof 4